Congratulations Drs. Okun, Hess and Vaillancourt on the publication of “Parkinson’s disease diffusion MRI is not affected by acute antiparkinsonian medication,” in the February issue of NeuroImage: Clinical.
Read the Abstract here:
A prior longitudinal study demonstrates that free-water diffusion magnetic resonance imaging (dMRI) tracks progression in the substantia nigra (Ofori et al., 2015b). Here, we test the acute effects of antiparkinsonian medication on this established imaging progression marker for the first time.